Rare Diseases Activities
Updates in Myelofibrosis: The Significance of JAK Inhibitors in Therapy
0290-0000-20-140-H01-P
This program will focus on evidence and nuances to available JAK inhibitors and discuss agents in the pipeline for myelofibrosis.
1.50
Examining Treatment Strategies for Myasthenia Gravis: A Specialty Pharmacist's Review
0290-0000-20-145-H01-P
Through this activity, pharmacists will become familiar with myasthenia gravis, its impact on patients, and the current treatment landscape with a focus on specialty medications.
1.00
Opportunities for Delivering Optimal Care in Spinal Muscular Atrophy
0290-0000-20-135-L01-P
This live webinar will examine the epidemiology, pathophysiology, clinical presentation, and diagnosis of spinal muscular atrophy (SMA).
6-25-2020
1.00
Treating Chronic Inflammatory Demyelinating Polyneuropathy With Immunoglobulin: Strategies for Appropriate Use and Accurate Dosing
0290-0000-20-095-L01-P
This live virtual symposium will examine the pathophysiology of chronic inflammatory demyelinating polyneuropathy (CIDP).
6-16-2020
1.00